Bolt Biotherapeutics BOLT
NASDAQ BOLT
$3.48 -0.20 (-5.43%)
As of: Oct 1, 2026 · 10:46 AM EDT

Bolt Biotherapeutics (BOLT) Return on Assets [ROA] (2021 - 2026)

Updated

Bolt Biotherapeutics (BOLT) posted Return on Assets [ROA] of -66.68% for Q2 2026, down 3.74 percentage points from -62.95% a year earlier and down 9.65 percentage points from the prior quarter.

Analysis

Bolt Biotherapeutics (BOLT) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Bolt Biotherapeutics' Return on Assets [ROA] came in at -42.99%, up 9.27 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a four-year change of +9.23 percentage points (FY2021 to FY2025).
  • In prior years, Bolt Biotherapeutics' Return on Assets [ROA] was -52.27% in FY2024 (-16.56 pp), -35.71% in FY2023 (-2.80 pp), -32.90% in FY2022 (+19.32 pp) and -52.23% in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Return on Assets [ROA] since Q1 2025.
  • On a year-over-year basis, Return on Assets [ROA] increased in two of the last eight quarters, with an average year-over-year change of -7.73 percentage points.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q1 2026, with a gain of 11.29 percentage points; the weakest was Q4 2024, with a drop of 23.59 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -57.04% (Q1 2026), -55.20% (Q4 2025) and -60.95% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Bolt Biotherapeutics 7.09 Mn 7.09 Mn - -66.68%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -66.68%
Mar 31, 2026 -57.04%
Dec 31, 2025 -55.20%
Sep 30, 2025 -60.95%
Jun 30, 2025 -62.95%
Mar 31, 2025 -68.32%
Dec 31, 2024 -64.88%
Sep 30, 2024 -59.75%
Jun 30, 2024 -53.05%
Mar 31, 2024 -44.74%
Dec 31, 2023 -41.29%
Sep 30, 2023 -38.95%
Jun 30, 2023 -38.70%
Mar 31, 2023 -37.51%
Dec 31, 2022 -37.23%
Sep 30, 2022 -37.67%
Jun 30, 2022 -35.69%
Mar 31, 2022 -33.13%
Dec 31, 2021 -28.85%
Sep 30, 2021 -24.17%
API Access

Bolt Biotherapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=BOLT&period=max&api_key=YOUR_API_KEY